DEA Letter to Georgia Board of Pharmacy Raises Novel Legal Issues

[Note from the editor: This article is about a letter that the DEA sent to the GA Board of Pharmacy that I wrote for the American Journal of Endocannabinoid Medicine. It is reprinted here with permission. You can read the article in its original form by clicking here.] On November 27, 2023, the Drug Enforcement Administration (DEA) […]

Go to Source

Powered by WPeMatico